Wednesday, 28 August 2024

🌎 EastGroup Properties Upgraded, Kite Realty Group Trust Upgraded, Phillips Edison & Company, Inc. Upgraded and more...

Ratings changes for EHang, Luna Innovations, Semtech, EyePoint Pharmaceuticals, Cognizant Technology Solutions, SB Financial Group, nCino and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
August 28th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • AeroVironment (NASDAQ:AVAV) was upgraded by analysts at Alembic Global Advisors from a "neutral" rating to an "overweight" rating. They now have a $216.00 price target on the stock. This represents a 7.5% upside from the current price of $200.88.
  • AeroVironment (NASDAQ:AVAV) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $220.00 price target on the stock, up previously from $161.00. This represents a 9.5% upside from the current price of $200.88.
  • Concentrix (NASDAQ:CNXC) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $85.00 price target on the stock, up previously from $65.00. This represents a 13.6% upside from the current price of $74.82.
  • Delek Logistics Partners (NYSE:DKL) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $44.00. This represents a 15.0% upside from the current price of $39.12.
  • EastGroup Properties (NYSE:EGP) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $214.00 price target on the stock, up previously from $179.00. This represents a 14.9% upside from the current price of $186.20.
  • Illumina (NASDAQ:ILMN) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $150.00 price target on the stock. This represents a 14.6% upside from the current price of $130.87.
  • Kite Realty Group Trust (NYSE:KRG) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $26.00 price target on the stock, up previously from $23.00. This represents a 0.2% downside from the current price of $26.06.
  • Moderna (NASDAQ:MRNA) was upgraded by analysts at HSBC Holdings plc from a "reduce" rating to a "hold" rating. They now have a $82.00 price target on the stock. This represents a 4.3% upside from the current price of $78.59.
  • ArcelorMittal (NYSE:MT) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $31.00 price target on the stock, up previously from $29.00. This represents a 32.4% upside from the current price of $23.41.
  • Grupo Aeroportuario del Pacífico (NYSE:PAC) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating.The current price is $174.05.
  • Phillips Edison & Company, Inc. (NASDAQ:PECO) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $37.00 price target on the stock, up previously from $34.00. This represents a 0.1% upside from the current price of $36.95.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Bank of Montreal (NYSE:BMO) (TSE:BMO) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $112.00 price target on the stock, down previously from $123.00. This represents a 36.8% upside from the current price of $81.88.
  • Bank of Montreal (NYSE:BMO) (TSE:BMO) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $117.00 price target on the stock, down previously from $134.00. This represents a 42.9% upside from the current price of $81.88.
  • Cinemark (NYSE:CNK) was downgraded by analysts at Barrington Research from an "outperform" rating to a "market perform" rating.The current price is $27.71.
  • Gannett (NYSE:GCI) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $5.10 price target on the stock. This represents a 6.8% downside from the current price of $5.47.
  • Lifecore Biomedical (NASDAQ:LFCR) was downgraded by analysts at Barrington Research from an "outperform" rating to a "market perform" rating.The current price is $3.93.
  • Semtech (NASDAQ:SMTC) was downgraded by analysts at Summit Insights from a "buy" rating to a "hold" rating.The current price is $39.43.
  • Terreno Realty (NYSE:TRNO) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $75.00 price target on the stock, up previously from $71.00. This represents a 8.3% upside from the current price of $69.24.
  • TransUnion (NYSE:TRU) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $94.98.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Arcutis Biotherapeutics (NASDAQ:ARQT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock. This represents a 41.0% upside from the current price of $10.64.
  • Byrna Technologies (NASDAQ:BYRN) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $14.00 price target on the stock. This represents a 24.7% upside from the current price of $11.23.
  • Cognizant Technology Solutions (NASDAQ:CTSH) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $90.00 price target on the stock. This represents a 15.9% upside from the current price of $77.66.
  • Diversified Energy (NYSE:DEC) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 45.0% upside from the current price of $12.41.
  • Quest Diagnostics (NYSE:DGX) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $165.00 price target on the stock. This represents a 6.7% upside from the current price of $154.69.
  • EHang (NASDAQ:EH) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $22.00 price target on the stock. This represents a 56.9% upside from the current price of $14.02.
  • enGene (NASDAQ:ENGN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 338.6% upside from the current price of $6.84.
  • EyePoint Pharmaceuticals (NASDAQ:EYPT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock. This represents a 67.4% upside from the current price of $8.96.
  • Fiserv (NYSE:FI) is now covered by analysts at BTIG Research. They set a "buy" rating and a $200.00 price target on the stock. This represents a 16.3% upside from the current price of $171.97.
  • GCT Semiconductor (NYSE:GCTS) is now covered by analysts at B. Riley. They set a "buy" rating and a $8.00 price target on the stock. This represents a 168.5% upside from the current price of $2.98.
  • (IHS) (NYSE:IHS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $5.00 price target on the stock. This represents a 44.5% upside from the current price of $3.46.
  • NewAmsterdam Pharma (NASDAQ:NAMS) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $36.00 price target on the stock. This represents a 115.4% upside from the current price of $16.71.
  • Nanobiotix (NASDAQ:NBTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock. This represents a 110.5% upside from the current price of $5.70.
  • Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $63.00 price target on the stock. This represents a 42.5% upside from the current price of $44.21.
  • SAB Biotherapeutics (NASDAQ:SABS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $12.00 price target on the stock. This represents a 318.1% upside from the current price of $2.87.
  • Vista Energy (NYSE:VIST) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $70.00 price target on the stock. This represents a 37.5% upside from the current price of $50.90.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Kamala Harris' Woke Politics Could Lead to 50% Stock Collapse

No comments:

Post a Comment

Did You See Trump's Bombshell Exec. Order 001?

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." It's a bombshell law that Trump...